| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,481 |
25,603 |
$4.16M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,277 |
15,536 |
$3.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,496 |
4,739 |
$1.22M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
9,923 |
4,202 |
$976K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,731 |
6,209 |
$645K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,413 |
2,960 |
$615K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
8,168 |
1,382 |
$463K |
| G0378 |
Hospital observation service, per hour |
1,415 |
1,204 |
$443K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,926 |
4,374 |
$414K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,523 |
9,299 |
$410K |
| 59025 |
Fetal non-stress test |
3,605 |
2,451 |
$376K |
| 71045 |
Radiologic examination, chest; single view |
7,559 |
6,624 |
$337K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,427 |
3,926 |
$283K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,172 |
4,067 |
$280K |
| 71046 |
Radiologic examination, chest; 2 views |
4,988 |
4,551 |
$228K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,687 |
2,201 |
$226K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,833 |
1,568 |
$226K |
| 30140 |
|
149 |
129 |
$200K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,358 |
1,095 |
$199K |
| 31276 |
|
37 |
36 |
$189K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,673 |
3,109 |
$174K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,814 |
1,557 |
$167K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,256 |
2,702 |
$163K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,144 |
6,172 |
$159K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,155 |
4,667 |
$151K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,812 |
2,357 |
$150K |
| 86900 |
|
2,411 |
2,034 |
$143K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,212 |
19,613 |
$142K |
| 87430 |
|
10,641 |
9,787 |
$135K |
| 54161 |
|
107 |
102 |
$132K |
| 80053 |
Comprehensive metabolic panel |
16,540 |
13,524 |
$130K |
| D7210 |
Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth |
387 |
158 |
$129K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
815 |
755 |
$121K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,084 |
948 |
$111K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,716 |
7,973 |
$107K |
| 31287 |
|
37 |
36 |
$105K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,527 |
3,287 |
$100K |
| 73560 |
|
2,005 |
1,650 |
$78K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,329 |
1,873 |
$74K |
| 73610 |
|
1,554 |
1,273 |
$68K |
| 73630 |
|
1,621 |
1,337 |
$65K |
| 86850 |
|
2,301 |
1,956 |
$65K |
| A0425 |
Ground mileage, per statute mile |
2,391 |
1,668 |
$63K |
| 31256 |
|
38 |
36 |
$62K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
629 |
580 |
$51K |
| 73030 |
|
1,227 |
1,022 |
$49K |
| 87077 |
|
3,323 |
2,735 |
$45K |
| 84703 |
|
7,691 |
6,464 |
$45K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,111 |
5,859 |
$44K |
| 86901 |
|
2,411 |
2,034 |
$44K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,870 |
2,023 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
18,286 |
14,104 |
$43K |
| 81001 |
|
19,153 |
15,942 |
$42K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,293 |
5,428 |
$39K |
| 70486 |
|
604 |
532 |
$39K |
| 76000 |
|
351 |
316 |
$38K |
| 73130 |
|
782 |
613 |
$37K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
314 |
309 |
$35K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
941 |
430 |
$34K |
| 86756 |
|
2,591 |
2,363 |
$33K |
| 73502 |
|
930 |
836 |
$32K |
| 97161 |
|
877 |
790 |
$32K |
| 73110 |
|
606 |
457 |
$29K |
| 72100 |
|
465 |
423 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,493 |
1,169 |
$26K |
| 83880 |
|
985 |
819 |
$26K |
| 97597 |
|
805 |
477 |
$25K |
| 84484 |
|
2,480 |
2,056 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
620 |
593 |
$24K |
| 94060 |
|
308 |
297 |
$24K |
| 87186 |
|
2,957 |
2,648 |
$23K |
| 36600 |
|
607 |
533 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,590 |
2,370 |
$18K |
| 74018 |
|
461 |
388 |
$18K |
| 83690 |
|
3,377 |
2,870 |
$18K |
| 80061 |
Lipid panel |
1,712 |
1,554 |
$18K |
| 73564 |
|
326 |
258 |
$17K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
165 |
153 |
$16K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
118 |
100 |
$16K |
| 84702 |
|
1,303 |
1,061 |
$15K |
| 87070 |
|
1,985 |
1,780 |
$14K |
| 87590 |
|
713 |
648 |
$14K |
| 97113 |
|
323 |
104 |
$14K |
| 62323 |
|
83 |
75 |
$14K |
| 87075 |
|
1,715 |
1,546 |
$13K |
| 94726 |
|
160 |
155 |
$13K |
| 15271 |
|
30 |
12 |
$13K |
| 87490 |
|
715 |
648 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
474 |
427 |
$12K |
| 94762 |
|
435 |
208 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
283 |
246 |
$12K |
| 82248 |
|
2,713 |
1,853 |
$12K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
31 |
26 |
$11K |
| 82803 |
|
620 |
545 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,500 |
1,345 |
$11K |
| 83874 |
|
999 |
878 |
$11K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
115 |
110 |
$11K |
| 97162 |
|
267 |
243 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
913 |
803 |
$10K |
| 82150 |
|
1,791 |
1,519 |
$9K |
| 82247 |
|
1,965 |
1,294 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
133 |
107 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
165 |
163 |
$9K |
| D1208 |
Topical application of fluoride, excluding varnish |
843 |
753 |
$8K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
13 |
13 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
300 |
287 |
$7K |
| 92585 |
|
29 |
28 |
$6K |
| D1120 |
Prophylaxis - child |
809 |
761 |
$6K |
| 82375 |
|
608 |
533 |
$6K |
| 83020 |
|
656 |
567 |
$6K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
121 |
74 |
$5K |
| 82820 |
|
607 |
532 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
17 |
15 |
$5K |
| 93925 |
|
68 |
68 |
$5K |
| D1206 |
Topical application of fluoride varnish |
830 |
780 |
$5K |
| 73140 |
|
87 |
66 |
$5K |
| 64493 |
|
14 |
14 |
$5K |
| 83735 |
|
877 |
566 |
$4K |
| 73590 |
|
95 |
76 |
$3K |
| 85730 |
|
732 |
655 |
$3K |
| 87040 |
|
260 |
226 |
$3K |
| 85610 |
|
1,008 |
864 |
$3K |
| 71250 |
|
77 |
66 |
$3K |
| 83050 |
|
606 |
533 |
$3K |
| 84100 |
|
855 |
542 |
$3K |
| 82962 |
|
1,194 |
650 |
$2K |
| 20610 |
|
25 |
25 |
$2K |
| 92652 |
|
15 |
14 |
$2K |
| 73090 |
|
47 |
38 |
$2K |
| 87210 |
|
630 |
566 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
27 |
$2K |
| 73070 |
|
62 |
40 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$2K |
| 85378 |
|
266 |
248 |
$2K |
| 86922 |
|
19 |
12 |
$2K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
213 |
187 |
$2K |
| 82607 |
|
142 |
135 |
$2K |
| 11045 |
|
1,081 |
497 |
$2K |
| 82570 |
|
1,013 |
942 |
$1K |
| 83605 |
|
143 |
130 |
$1K |
| 72040 |
|
33 |
27 |
$1K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
912 |
572 |
$1K |
| 77065 |
Tomosynthesis, mammo |
13 |
13 |
$925.38 |
| D2330 |
|
63 |
25 |
$838.12 |
| 90384 |
|
16 |
12 |
$763.12 |
| 93971 |
|
25 |
25 |
$728.55 |
| 83615 |
|
157 |
118 |
$702.66 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
12 |
$576.81 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$573.59 |
| 51701 |
|
12 |
12 |
$520.14 |
| 84550 |
|
149 |
112 |
$495.25 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
39 |
13 |
$462.57 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
278 |
251 |
$330.49 |
| 94664 |
|
3,930 |
2,509 |
$305.10 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,439 |
4,667 |
$303.64 |
| 85651 |
|
91 |
66 |
$277.70 |
| 0598T |
|
28 |
23 |
$244.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,780 |
6,672 |
$204.12 |
| 84156 |
|
150 |
120 |
$174.43 |
| 87205 |
|
96 |
90 |
$165.12 |
| J2704 |
Injection, propofol, 10 mg |
6,029 |
5,318 |
$158.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,850 |
8,352 |
$123.35 |
| 82270 |
|
38 |
36 |
$121.69 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,462 |
3,637 |
$98.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,902 |
4,293 |
$86.03 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
663 |
560 |
$57.25 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,499 |
4,031 |
$48.16 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,247 |
963 |
$22.54 |
| 80320 |
|
68 |
54 |
$20.86 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,710 |
4,224 |
$6.56 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,076 |
956 |
$2.78 |
| 96376 |
|
2,398 |
1,339 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,140 |
1,055 |
$0.00 |
| 99402 |
|
69 |
68 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,248 |
1,916 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
316 |
285 |
$0.00 |
| 36416 |
|
67 |
50 |
$0.00 |
| 61782 |
|
50 |
48 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
52 |
39 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
49 |
38 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
61 |
54 |
$0.00 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
50 |
37 |
$0.00 |
| 80050 |
General health panel |
16 |
15 |
$0.00 |
| 64494 |
|
12 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
30 |
24 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
17 |
15 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
505 |
450 |
$0.00 |
| J2950 |
Injection, promazine hcl, up to 25 mg |
793 |
643 |
$0.00 |
| 90715 |
|
384 |
354 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
498 |
402 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
760 |
668 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
138 |
126 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
233 |
202 |
$0.00 |
| 80323 |
|
805 |
772 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
42 |
37 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
312 |
294 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
108 |
107 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
98 |
54 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
232 |
139 |
$0.00 |
| 94729 |
|
185 |
180 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
61 |
49 |
$0.00 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
38 |
36 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
31 |
26 |
$0.00 |
| 99401 |
|
14 |
13 |
$0.00 |